Codagenix raises $20 million for a new flu vaccine and other therapies

Codagenix raises $20 million for a new flu vaccine and other therapies

/0 Comments/in , , /by

Coadagenix, a company developing vaccines and viral therapies for illnesses ranging from the flu and respiratory viruses to dengue fever has raised $20 million in a new round of financing.
The company’s new investment round was led by Adjuvant Capital with a…
Read More

You might also like
7 top mobility VCs discuss COVID-19 strategies and trends 7 top mobility VCs discuss COVID-19 strategies and trends
Virtual product placement is coming for TV and movies and Ryff has raised cash to put it there How to Get Rid of Samsung's Ads on Your Galaxy Phone
Equity Shot: What’s Elliott Management and why is it coming after Twitter and SoftBank? Equity Shot: What’s Elliott Management and why is it coming after Twitter and SoftBank?
The global chief investment strategist at $6.8 trillion BlackRock told us his 2 favorite trades to profit from a major shift that’s happening as recession fears fade away The global chief investment strategist at $6.8 trillion BlackRock told us his 2 favorite trades to profit from a major shift that's happening as recession fears fade away
Pandemic upends emerging market investment thesis – Reuters Pandemic upends emerging market investment thesis - Reuters
Spotify spent a lot of money on podcasting, so it wants you to start listening, please Spotify spent a lot of money on podcasting, so it wants you to start listening, please
S&P 500 Buybacks Now Outpace All R&D Spending in the US S&P 500 Buybacks Now Outpace All R&D Spending in the US
Virtual product placement is coming for TV and movies and Ryff has raised cash to put it there Virtual product placement is coming for TV and movies and Ryff has raised cash to put it there
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *